New coaching program helps seniors decide on dialysis with confidence

NCT ID NCT04392440

Completed Knowledge-focused Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called DIAL-SDM that trains kidney doctors and coaches older patients (65+) with advanced kidney disease to have better conversations about dialysis. The goal was to see if the program was practical and acceptable. 102 patients, their caregivers, and 20 doctors took part. The results showed the program was feasible and well-liked, but this was a small pilot study, so more research is needed to know if it actually improves decisions or health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: communication training and coaching program
What this could lead to: If this approach works, it could help older kidney patients make more informed, values-aligned decisions about dialysis, potentially improving quality of life and reducing regret.
What could go wrong: This is a small pilot study focused on feasibility, not on health outcomes. The intervention may not change actual dialysis decisions or improve survival, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES END-STAGE RENAL DISEASE

Contacts and locations

Locations

University of Rochester

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.